Late-effects of Chemoradiotherapy on Growth and Puberty in Survivors of Childhood Acute Lymphoblastic Leukemia

被引:0
|
作者
Eltan, Sevgi Bilgic [1 ]
Akcay, Arzu [2 ]
Bayramoglu, Elvan [3 ]
Eltan, Mehmet [4 ]
Akcay, Teoman [5 ]
Salcioglu, Zafer [5 ]
Aydogan, Gonul [6 ]
机构
[1] Marmara Univ, Dept Pediat Allergy & Immunol, Fac Med, Istanbul, Turkiye
[2] Acibadem Mehmet Ali Aydinlar Univ, Altunizade Hosp, Fac Med, Clin Pediat Hematol & Oncol, Istanbul, Turkiye
[3] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Pediat Endocrinol, Istanbul, Turkiye
[4] Univ Hlth Sci Turkiye, Istanbul Sancaktepe Sehit Prof Dr Ilhan Varank Tra, Clin Pediat Endocrinol, I?stanbul, Turkiye
[5] Uskudar Univ, Sisli Mem Hosp, Clin Pediat, Fac Med, I?stanbul, Turkiye
[6] Univ Hlth Sci Turkiye, Istanbul Kanuni Sultan Suleyman Training & Res Hos, Clin Pediat Hematol & Oncol, I?stanbul, Turkiye
来源
TRENDS IN PEDIATRICS | 2022年 / 3卷 / 04期
关键词
Acute lymphoblastic leukemia; growth; late effects; puberty; obesity; BODY-MASS-INDEX; CRANIAL IRRADIATION; BINDING PROTEIN-3; REFERENCE VALUES; ADULT SURVIVORS; SHORT STATURE; CHILDREN; HEIGHT; CHEMOTHERAPY; PATTERNS;
D O I
10.4274/TP.2022.43043
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: The survival rate of childhood leukemia has reached 80% with evolving treatment modalities over the last 30 years, which is followed by an increased incidence of treatment -related long-term side effects. This study, it was aimed to evaluate the endocrine late effects of chemoradiotherapy in childhood acute lymphoblastic leukemia (ALL). Methods: Forty-eight patients with ALL treated at the University of Health Sciences T & uuml;rkiye, & Idot;stanbul Kanuni Sultan S & uuml;leyman Training and Research Hospital, Clinic of Pediatric Hematology and Oncology between 1997 and 2007 with at least 5 -year follow-up after the chemotherapy, were included. Results: Endocrine side effects were detected in 48% (n=23) of the cases. The most common endocrine side effect was short stature in the group treated with cranial radiotherapy (CRT), and obesity in the group that did not receive CRT. The median height standard deviation score (SDS) of the subjects who reached the final height (FH) was significantly lower [-1.44 (-2.1)-(-0.53)] compared with the median height SDS of the subjects who did not reach the FH [-0.24 (-1.23)-(0.6)]. There was a positive correlation between height SDS and IGF1 SDS, IGFBP3 SDS, body mass index SDS, and advanced bone age in subjects who did not reach FH (r=0.511, p=0.018, r=0.530, p=0.014, r=0.499, p=0.021, r=0.599, p=0.08, respectively). Precocious puberty was found in one patient who received CRT, and hypergonadotropic hypogonadism was found in one patient who did not receive CRT. Twenty-three percent of the group received CRT and 35% of the group who did not receive CRT had overweight/obesity. Central hypothyroidism was detected in one case and subclinical hypothyroidism was detected in two cases. Conclusion: Long-term endocrine side effects were observed in approximately half of the cases with childhood ALL. Children treated with chemoradiotherapy should have endocrine evaluation and from the until the is
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [21] Alterations in body composition in survivors of childhood acute lymphoblastic leukemia
    Hamama, Eman
    El-Sherif, Marwa
    El-Asrar, Mohamed
    Makkeyah, Sara
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2021, 46 (04) : 249 - 254
  • [22] Fatigue in survivors of childhood acute lymphoblastic and myeloid leukemia in Japan
    Nagai, Ayako
    Zou, Ning
    Kubota, Masaru
    Kojima, Chiaki
    Adachi, Souichi
    Usami, Ikuya
    Okada, Masayuki
    Tanizawa, Akihiko
    Hamahata, Keigo
    Matsubara, Kousaku
    Higuchi, Manryoku
    Imaizumi, Masue
    PEDIATRICS INTERNATIONAL, 2012, 54 (02) : 272 - 276
  • [23] Obesity in patients with acute lymphoblastic leukemia in childhood
    Iughetti, Lorenzo
    Bruzzi, Patrizia
    Predieri, Barbara
    Paolucci, Paolo
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [24] Analysis of linear growth in survivors of childhood acute lymphoblastic leukemia
    Yamashita, N
    Tanaka, H
    Moriwake, T
    Nishiuchi, R
    Oda, M
    Seino, Y
    JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (03) : 172 - 178
  • [25] Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapy
    Iijima, Mayuko
    Liu, Wei
    Panetta, John C.
    Hudson, Melissa M.
    Pui, Ching-Hon
    Srivastava, Deo Kumar
    Krull, Kevin R.
    Inaba, Hiroto
    CANCER, 2021, 127 (17) : 3202 - 3213
  • [26] Sarcopenic obesity in survivors of childhood acute lymphoblastic leukemia: prevalence, risk factors, and implications for cancer survivors
    Das, Gargi
    Setlur, Kritika
    Jana, Manisha
    Ramakrishnan, Lakshmy
    Jain, Vandana
    Meena, Jagdish Prasad
    Gupta, Aditya Kumar
    Dwivedi, Sadanand
    Seth, Rachna
    SUPPORTIVE CARE IN CANCER, 2024, 32 (12)
  • [27] Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors
    Hata, M
    Ogino, I
    Aida, N
    Saito, K
    Omura, M
    Kigasawa, H
    Toyoda, Y
    Tachibana, K
    Matsubara, S
    Inoue, T
    INTERNATIONAL JOURNAL OF CANCER, 2001, 96 : 117 - 124
  • [28] Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia
    Malhotra, Payal
    Kapoor, Gauri
    Jain, Sandeep
    Jain, Silky
    Sharma, Anurag
    INDIAN PEDIATRICS, 2021, 58 (05) : 436 - 440
  • [29] Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors
    Shalmiev, A.
    Nadeau, G.
    Aaron, M.
    Ouimet-Grennan, E.
    Drouin, S.
    Bertout, L.
    Beaulieu, P.
    St-Onge, P.
    Veilleux, L. -N.
    Rauch, F.
    Rezgui, A.
    Petrykey, K.
    Laverdiere, C.
    Sinnett, D.
    Alos, N.
    Krajinovic, M.
    PHARMACOGENOMICS JOURNAL, 2022, 22 (01) : 19 - 24
  • [30] The Prevalence, Risk Factors and Cardiometabolic Complications of Obesity in Childhood Survivors of Acute Lymphoblastic Leukemia
    Cebeci, Dilek
    Kaya, Zuhre
    Bideci, Aysun
    Kocak, Uelker
    Yilmaz, Canan
    Gursel, Tuerkiz
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 415 - 422